Similar articles

• [Glucose abnormalities in a 14-year old patient treated with a second generation antipsychotic].

  Lauwers K, de Hert M, de Rijdt L, Peuskens J. Lauwers K, et al. Tijdschr Psychiatr. 2006;48(4):331-5. Tijdschr Psychiatr. 2006. PMID: 16955998 Dutch.
• Elucidating the role of risperidone in the treatment of disruptive behavior disorders.

  Shatkin JP. Shatkin JP. J Child Adolesc Psychopharmacol. 2006 Aug;16(4):377-8. doi: 10.1089/cap.2006.16.377. J Child Adolesc Psychopharmacol. 2006. PMID: 16958563 No abstract available.
• [Pediatric psychiatry: children and antipsychotic drugs: clinical monitoring by the nurse assures a safe course in children taking antipsychotic drugs].

  Fournier A, Laflamme F. Fournier A, et al. Perspect Infirm. 2010 Sep-Oct;7(5):19-21. Perspect Infirm. 2010. PMID: 21744626 French. No abstract available.
• Treatment of behavior disorders in mental retardation: report on transitioning to atypical antipsychotics, with an emphasis on risperidone.

  Aman MG, Gharabawi GM; Special Topic Advisory Panel on Transitioning to Risperidone Therapy in Patients With Mental Retardation and Developmental Disabilities. Aman MG, et al. J Clin Psychiatry. 2004 Sep;65(9):1197-210. J Clin Psychiatry. 2004. PMID: 15367046 Review.
• Risperidone in pervasive developmental disorders.

  Erickson CA, Stigler KA, Posey DJ, McDougle CJ. Erickson CA, et al. Expert Rev Neurother. 2005 Nov;5(6):713-9. doi: 10.1586/14737175.5.6.713. Expert Rev Neurother. 2005. PMID: 16274329 Review.